Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 131 publications
Consensus on Biomarker Utility for ACTH-Dependent Cushing's Syndrome: A Pituitary Society Modified Delphi Panel.
Journal: The Journal of clinical endocrinology and metabolism
Published: May 07, 2026
Long-acting growth hormone: An updated Growth Hormone Research Society consensus statement.
Journal: European journal of endocrinology
Published: May 06, 2026
Impact of Osilodrostat on Health-Related Quality of Life in Cushing's Disease: Analysis of Patient-Reported Outcomes From the Phase III LINC 3 and LINC 4 Clinical Trials.
Journal: Clinical endocrinology
Published: February 09, 2026
Developments in Pharmacotherapy for Acromegaly: Current and Emerging Approaches.
Journal: Drugs
Published: January 30, 2026
Controlling cortisol excess and comorbidities in Cushing's syndrome with osilodrostat.
Journal: Pituitary
Published: October 13, 2025
Efficacy and Safety of Once-Weekly Lonapegsomatropin in Adults With Growth Hormone Deficiency: foresiGHt Trial Results.
Journal: The Journal of clinical endocrinology and metabolism
Published: September 02, 2025
Clinical Pearls From JCEM Case Reports: ENDO 2025.
Journal: JCEM case reports
Published: August 25, 2025
Consensus on acromegaly therapeutic outcomes: an update.
Journal: Nature reviews. Endocrinology
Published: June 30, 2025
Rapid and Sustained Response of Biochemically Uncontrolled Acromegaly to Once-daily Oral Paltusotine Treatment.
Journal: The Journal of clinical endocrinology and metabolism
Published: June 23, 2025
Correction to: Osilodrostat improves blood pressure and glycemic control in patients with Cushing's disease: a pooled analysis of LINC 3 and LINC 4 studies.
Journal: Pituitary
Published: May 21, 2025
Last Updated: 09/26/2026